This finding pushes the search for better dengue vaccines toward the place where infection begins and where protection may be decided earliest.<\/p>\n Evidence under skin<\/p>\n Inside fluid-filled blisters raised on volunteers\u2019 forearms in Singapore, the clearest signs of dengue\u2019s immune fight appeared in skin rather than blood.<\/p>\n Working with matched samples from 73 patients, Laura Rivino at the University of Bristol<\/a> found that the most active T-cell responses were concentrated at that surface site.<\/p>\n Those skin-based cells looked especially prominent during the phase of illness when the body\u2019s defense was peaking, and they were strongest in people who avoided admission.<\/p>\n The pattern does not settle every reason that dengue turns severe, but it sharply narrows where the next answers are likely to emerge.<\/p>\n Skin matters in dengue vaccines<\/p>\n Dengue infection begins in the skin, not the bloodstream, when an infected mosquito<\/a> deposits the virus during a bite.<\/p>\n Cells stationed there can react before infection spreads, and those local defenders include T-cells, white blood cells that recognize infected targets.<\/p>\n Blood tests have dominated dengue research for years, yet blood can miss the tissue fight that is already underway.<\/p>\n By moving the search to skin, the new work changed where scientists look for protection.<\/p>\n Cells that stay<\/p>\n Many of the activated cells in the skin<\/a> looked ready to stay there within seven to ten days after fever began.<\/p>\n Immunologists call that group tissue-resident memory T-cells. These long-lived defenders stay in tissue instead of constantly recirculating.<\/p>\n Markers on those skin cells suggested they were settling in place while loading destructive proteins that help destroy infected cells.<\/p>\n If vaccines can build more of them at the bite site, protection against dengue might start faster during the next encounter.<\/p>\n Protection and severity<\/p>\n Protection showed up most clearly when clinicians compared people sent home with patients sick enough to need admission.<\/p>\n Those CD8+ T-cells \u2013 immune cells that kill infected cells \u2013 were more abundant in skin and blood<\/a> among people sent home.<\/p>\n \u201cAs dengue spreads worldwide, there is an urgent need to identify the immune responses that protect against infection and severe disease,\u201d said Dr. Rivino.<\/p>\n Her team\u2019s comparison does not settle every cause of severe dengue, but it narrows one part of the mystery.<\/p>\n Signals in blisters<\/p>\n Blister fluid from people sent home also held more cytokines, chemical messages that help immune cells coordinate attacks.<\/p>\n Among them were signals strongly linked to T-cell<\/a> growth, tissue memory, and local recruitment during illness.<\/p>\n Signal levels were highest in people sent home, lower in later-admitted patients, and even lower in those hospitalized earlier.<\/p>\n That gradient made the skin response look less like a side effect and more like useful protection.<\/p>\n Blood and skin link<\/p>\n Links between skin and blood appeared in the cells\u2019 receptor patterns, not just in their sheer numbers.<\/p>\n Some shared clonotypes \u2013 T-cells with the same receptor pattern \u2013 appeared in skin and blood from two patients.<\/p>\n Researchers could not tell whether those matching groups moved between places or grew from a common starting pool.<\/p>\n Either possibility helps explain why blood tracked part of the skin response instead of telling a completely separate story.<\/p>\n Dengue vaccine problem today<\/p>\n One estimate<\/a> puts dengue infections worldwide near 390 million a year, which keeps the vaccine challenge enormous.<\/p>\n Right now, the only World Health Organization-recommended vaccin<\/a>e<\/a> for dengue is limited to use in children ages six through 16 in high-transmission settings.<\/p>\n \u201cThe findings could have significant implications for vaccination, and eliciting dengue-specific skin-resident CD8+ T-cells could improve vaccine effectiveness,\u201d said Rivino.<\/p>\n Such a strategy points toward vaccines or delivery routes designed to build strong defenders exactly where mosquitoes deposit the dengue virus.<\/p>\n Earlier clue in dengue skin returns<\/p>\n That trail did not come out of nowhere, because earlier work had already hinted that dengue-fighting cells were skin-bound.<\/p>\n Back in 2015, Rivino\u2019s group found a skin-targeting surface marker<\/a> on dengue-specific blood T-cells.<\/p>\n The new work places those cells inside skin itself, where they appear active, abundant, and tied to milder illness.<\/p>\n It closes part of the gap between what blood hinted at years ago and what tissue now plainly shows.<\/p>\n Limits that matter<\/p>\n Some gaps still matter before vaccine makers bet heavily on skin-focused strategies for large public health programs.<\/p>\n The deepest gene and receptor sequencing came from only three patients, and the most precise tracking of virus-specific cells involved eight.<\/p>\n Researchers also could not separate cell movement from shared ancestry, and they did not compare protection across all four viral types.<\/p>\n Those limits keep the result promising rather than final, while making the next round of studies easy to define.<\/p>\n Where this leads<\/p>\n Dengue looked less like a disease explained by blood alone and more like one decided partly in skin.<\/p>\n A vaccine that reaches that tissue response will still need larger proof, but the target is finally clearer.<\/p>\n The study is published in Science Advances<\/a>.<\/p>\n \u2014\u2013<\/p>\n Like what you read?\u00a0Subscribe to our newsletter<\/a>\u00a0for engaging articles, exclusive content, and the latest updates.<\/p>\n Check us out on\u00a0EarthSnap<\/a>, a free app brought to you by\u00a0Eric Ralls<\/a>\u00a0and Earth.com.<\/p>\n \u2014\u2013<\/p>\n","protected":false},"excerpt":{"rendered":"The search for better vaccines against dengue fever has taken a new direction due to the results of…\n","protected":false},"author":2,"featured_media":370670,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[103,61,60],"class_list":{"0":"post-370669","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-health","8":"tag-health","9":"tag-ie","10":"tag-ireland"},"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts\/370669","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/comments?post=370669"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts\/370669\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/media\/370670"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/media?parent=370669"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/categories?post=370669"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/tags?post=370669"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\n ![\"EarthSnap\"\/](\"https:\/\/www.newsbeep.com\/ie\/wp-content\/uploads\/2025\/09\/earthsnap-banner-news.webp.webp\")
\n<\/a><\/p>\n